X0508 4 2025-11-16 0 0001743881 BridgeBio Pharma, Inc. BBIO 0002030813 Trimarchi Thomas C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250 PALO ALTO CA 94304 0 1 0 0 President and CFO 1 Common Stock 2025-11-16 4 F 0 21317 66.39 D 399764 D Common Stock 2025-11-17 4 S 0 9978 66.1923 D 389786 D Common Stock 2025-11-17 4 S 0 6956 66.8398 D 382830 D Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 38,547 shares of Common Stock underlying the Reporting Person's Restricted Stock Units. This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025. Represents the weighted average sale price of the shares sold from $65.575 to $66.57 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. Represents the weighted average sale price of the shares sold from $66.61 to $67.26 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. /s/ Will Solis, Attorney-in-Fact 2025-11-18